Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

SignalRx Pharmaceuticals (United States) | Researchclopedia

Back to institutions

SignalRx Pharmaceuticals (United States)

San Diego, Californiacompany

176

Works

62,641

Citations

95

h-index

Top Research Topics

NF-κB Signaling Pathways Cytokine Signaling Pathways and Interactions Protein Kinase Regulation and GTPase Signaling

Top Researchers

Matthias Mann Max Planck Institute of Biochemistry

1,422 works299,169 citationsh-index: 250

Recent Research

PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia

Britten Gordon,Elizabeth M. Muhowski,et al.

20251 citations

Immune Response and Inflammation

Ubiquitin and proteasome pathways

Melanoma and MAPK Pathways

Protein Degradation and Inhibitors

Synthesis and biological activity

Chemical Synthesis and Analysis

interferon and immune responses

DNA Repair Mechanisms

Cell death mechanisms and regulation

Michael Karin Discovery Institute

901 works270,669 citationsh-index: 254

Ruedi Aebersold ETH Zurich

1,181 works172,385 citationsh-index: 198

Steven P. Gygi Harvard University

1,012 works170,495 citationsh-index: 195

Nahum Sonenberg Montreal Neurological Institute and Hospital

955 works124,256 citationsh-index: 178

Anjana Rao La Jolla Institute for Immunology

410 works73,487 citationsh-index: 127

LC–MS/MS method for the quantitation of a dual PI3K/BRD4 inhibitor SF2523 in mouse plasma: Application to plasma protein binding and metabolism studies

Veenu Bala,Yashpal S. Chhonker,et al.

20232 citations

The Effects of Nitrate-Based Nutritional Formula on Oxygen Saturation and Patient-Reported Outcomes in COVID-19 Patients: A Randomized Controlled Trial

Nikola Todorović,Valdemar Štajer,et al.

20220 citations

Nitric Oxide: The Missing Factor in COVID-19 Severity?

Alexandros Nikolaidis,Ron Kramer,et al.

202123 citations

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

Yongsheng Ruan,Hye Na Kim,et al.

20212 citations

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

Dhananjaya Pal,Kendra R. Vann,et al.

202114 citations